Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Comments(1)

CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer

Francisco J Esteva email, Jing Wang email, Feng Lin email, Jaime A Mejia email, Kai Yan email, Kadri Altundag email, Vicente Valero email, Aman U Buzdar email, Gabriel N Hortobagyi email, W Fraser Symmans email and Lajos Pusztai email

Breast Cancer Research 2007, 9:R87doi:10.1186/bcr1836

Additional data for this article

Claire Hansford   (13 November 2008)  BioMed Central email

Due to a technical fault the additional file links have become unavailable for this article.

They are now available from:

Additional file 1: http://www.biomedcentral.com/content/

supplementary/bcr1836-S1.xls

Additional file 2: http://www.biomedcentral.com/content/

supplementary/bcr1836-S2.xls

Additional file 3: http://www.biomedcentral.com/content/

supplementary/bcr1836-S3.xls

Competing interests

None declared

top

Have something to say? Post a comment on this article!

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.